Back to search

National and Kapodistrian University of Athens

Η επίδραση της προδιαστολής πριν τη διακαθετηριακή εμφύτευση βιοπροσθετικής αυτοεκπτυσσόμενης αορτικής βαλβίδας στη βραχυπρόθεσμη και μακροπρόθεσμη έκβαση των ασθενών που υποβάλλονται σε αυτήν

Abstract

dc:description

Balloon aortic valvuloplasty (BAV) has been used prior to valve implantation of a self- expandable valve as part of the transcatheter aortic valve implantation (TAVI) procedure. We aimed to evaluate the impact of BAV prior to TAVI. We studied 262 consecutive patients who were treated either with (pre-BAV- TAVI group) or without BAV (D-TAVI group). Implantation depth (ID) was angiographically measured at non-coronary cusp (NCC) and left coronary cusp (LCC) at: the starting point (stage-1), before (stage-2), and after (stage-3) final bioprosthesis release. Paravalvular regurgitation (PVR) was assessed after implantation, at discharge, at 1st and 6th month after TAVI and 1-year clinical follow-up were recorded. Overall, from stage-1 to stage-3, prosthesis migrated toward the left ventricle,in both cusps and groups. At NCC a forward migration was observed from stage-1 to stage-2 in both groups (p < 0.001). In the pre-BAV-TAVI group only, at NCC, an upward migration decreased the ID from stage-2 to stage-3 (p = 0.022). PVR >=grade 2, immediately after expansion was more frequently observed in pre-BAV-TAVI group (37,1% vs 10,1%, respectively; p<0,001). However, PVR was similar at discharge, 1st and 6th month after TAVI. Clinical parameters were comparable between the two groups. In pre-BAV-TAVI group left bundle branch block (LBBB) was more frequently observed vs D-TAVI group (26% vs 13%, p=0,018), but the frequency of permanent pacemaker implantation after TAVI did not differ between the two groups. In addition, BAV didn’ t increase the risk of stroke or death from any cause over time during the first year of follow-up. Finally, it was observed that patients with left ventricular ejection fraction (LVEF)< 50% at discharged appear to have 15% lower survival probability during the first year of follow-up after TAVI. The use of BAV prior to TAVI may have an impact on device final position, PVL and LBBB, but not on short- and long-term clinical outcome. Future studies are needed to investigate the safety and outcomes of direct TAVI and to identify which patients must safely undergo pre-BAV TAVI approach.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lavda, Maria
  • Λάβδα, Μαρία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49333

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lavda, Maria; Λάβδα, Μαρία. Η επίδραση της προδιαστολής πριν τη διακαθετηριακή εμφύτευση βιοπροσθετικής αυτοεκπτυσσόμενης αορτικής βαλβίδας στη βραχυπρόθεσμη και μακροπρόθεσμη έκβαση των ασθενών που υποβάλλονται σε αυτήν. National and Kapodistrian University of Athens, 2021. http://hdl.handle.net/10442/hedi/49333